These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8731322)

  • 21. The effect of etofibrate retard, bezafibrate and procetofen.
    Luley C; Schwartzkopff W; Schilling A; Calder D; Scheffler W
    Artery; 1980; 8(2):128-33. PubMed ID: 7458677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The beneficial effects of lipid-lowering drugs beyond lipid-lowering effects: a comparative study with pravastatin, atorvastatin, and fenofibrate in patients with type IIa and type IIb hyperlipidemia.
    Saklamaz A; Comlekci A; Temiz A; Caliskan S; Ceylan C; Alacacioglu A; Yesil S
    Metabolism; 2005 May; 54(5):677-81. PubMed ID: 15877299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet functions and lipid profile in haemorrhagic and thrombotic stroke patients.
    Garg RK; Gaur SP; Kar AM; Srimal RC
    J Assoc Physicians India; 1994 Apr; 42(4):294-7. PubMed ID: 7860545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The range and lipid-lowering effect of etofibrate as a retard-preparation in patients with hyperlipoproteinemia type IIa (author's transl)].
    Mertz DP; Loewer H; Suermann I
    Med Klin; 1979 Dec; 74(51-52):1953-6. PubMed ID: 542179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of a hypocaloric diet on lipids and rheological profile in subjects with severe and morbid obesity. A follow-up study.
    Solá E; Vayá A; Contreras T; Falcó C; Corella D; Hernández A; Aznar J
    Clin Hemorheol Microcirc; 2004; 30(3-4):419-22. PubMed ID: 15258377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of low cholesterol, linoleic acid enriched diet on thrombotic tendency and plasma lipoproteins in patients with angina pectoris.
    Turek JV; Houtsmuller UM; Lussenburg RN; den Ottolander GJ
    Artery; 1980; 8(2):134-9. PubMed ID: 7458678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lipid-lowering effect of etofibrate, bezafibrate and xanthinol nicotinate in patients with hyperlipoproteinemias].
    Machalke K; Djaja S; Richter E
    Ther Ggw; 1982 May; 121(5):301-11. PubMed ID: 6953613
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of D-003, a mixture of long-chain aliphatic primary acids, fluvastatin and the combined therapy of D-003 plus fluvastatin on the lipid profile of normocholesterolemic rabbits.
    Mendoza S; Gamez R; Mas R; Goicochea E
    Int J Tissue React; 2003; 25(3):81-9. PubMed ID: 14756189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Panax notoginseng (Burk.) effects on fibrinogen and lipid plasma level in rats fed on a high-fat diet.
    Cicero AF; Vitale G; Savino G; Arletti R
    Phytother Res; 2003 Feb; 17(2):174-8. PubMed ID: 12601683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of treating glomerulonephritis with omega 3 fatty acids for selected parameters of hemostasis, blood platelet function and lipid metabolism].
    Małyszko JS; Małyszko J; Pawlak K; Myśliwiec M
    Przegl Lek; 1996; 53(8):600-3. PubMed ID: 8999460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Long-term treatment of hyperlipoproteinemia with etofibrate].
    Bartz VT; Gatz J; Slotty C; Schröter C; Töle R; Wand P
    Fortschr Med; 1993 Sep; 111(25):398-400. PubMed ID: 8406286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-prandial effects of gemfibrozil vs simvastatin in hypercholesterolemic subjects with borderline hypertriglyceridemia.
    Vigna GB; Donega P; Passaro A; Zanca R; Cattin L; Fonda M; Pauciullo P; Marotta G; Fellin R; Gasparrini S; Piliego T
    Nutr Metab Cardiovasc Dis; 1999 Oct; 9(5):234-43. PubMed ID: 10656170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Atherosclerosis treatment with etofibrate retard. New perspectives].
    Degenring FH; Schatton W; Hotz W
    Fortschr Med; 1983 Aug; 101(30):1391-6. PubMed ID: 6618402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prothrombotic and lipoprotein variables in patients attending a cardiovascular risk management clinic: response to ciprofibrate or lifestyle advice.
    Mikhailidis DP; Ganotakis ES; Spyropoulos KA; Jagroop IA; Byrne DJ; Winder AF
    Int Angiol; 1998 Dec; 17(4):225-33. PubMed ID: 10204653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fenofibrate decreases plasma fibrinogen, improves lipid profile, and reduces uricemia.
    de la Serna G; Cadarso C
    Clin Pharmacol Ther; 1999 Aug; 66(2):166-72. PubMed ID: 10460070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Bile lipid composition in subjects with blood lipid disorders (types II and IV). Effect of a new hypolipemic drug (Etofibrate)].
    Altomonte L; Mingrone G; Ghirlanda G; Manna R; Rebuzzi A; Pala MA; Greco AV
    Minerva Med; 1980 Feb; 71(4):273-8. PubMed ID: 7354946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of kiwi fruit consumption on platelet aggregation and plasma lipids in healthy human volunteers.
    Duttaroy AK; Jørgensen A
    Platelets; 2004 Aug; 15(5):287-92. PubMed ID: 15370099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study.
    Nickelsen T; Creatsas G; Rechberger T; Depypere H; Erenus M; Quail D; Arndt T; Bonnar J;
    Climacteric; 2001 Dec; 4(4):320-31. PubMed ID: 11770189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of fenofibrate on serum paraoxonase activity and inflammatory markers in patients with combined hyperlipidemia.
    Yesilbursa D; Serdar A; Saltan Y; Serdar Z; Heper Y; Guclu S; Cordan J
    Kardiol Pol; 2005 Jun; 62(6):526-30. PubMed ID: 16123850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short-term diets enriched in stearic or palmitic acids do not alter plasma lipids, platelet aggregation or platelet activation status.
    Kelly FD; Sinclair AJ; Mann NJ; Turner AH; Raffin FL; Blandford MV; Pike MJ
    Eur J Clin Nutr; 2002 Jun; 56(6):490-9. PubMed ID: 12032647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.